Retinal diseases are one of the leading causes of blindness worldwide, and early detection is crucial in preventing permanent vision loss. Traditional fundus cameras provide a valuable tool for detecting these diseases, but their efficacy may be limited in some cases. Fortunately, advances in technology have led to the development of the ICGA-enabled fundus camera, which offers enhanced capabilities for retinal disease detection. ICGA stands for Indocyanine Green Angiography, a non-invasive imaging technique that uses a specialized dye to visualize blood vessels in the retina. This allows for better identification of abnormalities in the retinal vasculature, which can indicate a variety of retinal diseases such as diabetic retinopathy, age-related macular degeneration, and retinal vein occlusion. The ICGA-enabled fundus camera combines traditional fundus photography with the added benefit of ICGA. The camera is equipped with an infrared laser, which illuminates the indocyanine green dye in the blood vessels of the retina, providing a detailed map of the vasculature. This technology has several advantages over traditional fundus cameras. Firstly, it can detect subtle abnormalities in the vasculature that may not be visible with traditional camera techniques. Secondly, it provides better visualization of blood flow in the retina than traditional fluorescein angiography, which uses a different dye. Finally, it offers the ability to image deeper layers of the retina which may be difficult to visualize with traditional cameras. ICGA-enabled fundus cameras are particularly useful in the early detection and monitoring of diabetic retinopathy, a common complication of diabetes that can lead to vision loss. Early detection allows for timely intervention, such as laser treatment, to prevent vision loss. Overall, the ICGA-enabled fundus camera represents a significant advance in the detection and management of retinal diseases. Its enhanced capabilities offer better visualization of the retinal vasculature, allowing for earlier detection and more targeted treatment of retinal diseases. With continued advances in technology, it is likely that ICGA-enabled fundus cameras will become more widely available, improving the diagnosis and management of retinal diseases for patients around the world.